On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 1, 2000, Pages 43-48

  Wizemann, V ^a   Lotz, C ^a   Techert, F ^a   Uthoff, S ^b  

^a Georg Haas Dialysezentrum   (Germany)

^b Fresenius MC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; ERYTHROPOIETIN; POLYSULFONE; PREALBUMIN; SERUM ALBUMIN; TRANSFERRIN;

ADULT; AGED; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DIALYSIS MEMBRANE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDRATION; HYPOTENSION; INTERMETHOD COMPARISON; MALE; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; ONLINE SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKINFOLD THICKNESS; UREMIA;

EID: 0034004781     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027963     Document Type: Conference Paper

References (15)

1. Held P, Port F, Wolfe R, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556
2. Cheung A. Quantification of dialysis. Blood Purif 1994; 12: 42-53
3. Birk HW, Kistner A, Wizemann V, Schütterte G. Protein adsorption by artificial membrane materials under filtration conditions. Artif Organs 1995; 19: 411-415
4. Daugirdas J. Second generation logarithmic estimates of single pool variable Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213
5. Wizemann V, Schilling M. The dilemma of assessing volume state - the use and the limitation of a clinical score. Nephrol Dial Transplant 1995; 10: 2114-2117
6. Kerr P, Argilis A, Flavier J-L, Canaud B, Mion C. Comparison of hemodialysis and hemodiafiltration: A long-term longitudinal study. Kidney Int 1992; 41: 1035-1040
7. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, LaGreca D, Orlandini G. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996; 50: 1293-1302
8. Küchle C, Fricke H, Held E, Schiffl H. High-flux hemodialysis postpones clinical manifestation of dialysis related amyloidosis. Am J Nephrol 1996; 16: 484-488
9. Lowry E, New H. Death risk in hemodialysis patients: the predictive value of commonly measured variables and on evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
10. Druml W. Malnutrion is bad, but how can one detect malnutrion. Nephrol Dial Transplant 1997; 12: 2225-2227
11. Kaysen G, Rathore V, Shearer G, Depner T. Mechanism of hypalbuminemia in hemodialysis patients. Kidney Int 1995; 48: 510-516
12. Wizemann V, Birk H-W, Techert F. Effects of a modified hemodiafiltration method on low-molecular weight proteins. Blood Purif 1990; 8: 45-51
13. Brunet P, Saingra Y, Leonetti F, Vacher-Coponat H, Ramananrivo P, Berland Y. Tolerance of haemodialysis: a randomized cross-over trial of 5h versus 4h treatment time. Nephrol Dial Transplant 1996; 11 (Suppl. 8): 46-51
14. Ifudo O, Feldmann J, Friedmann E. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-425
15. 2-Mikroglobulin unter Sterilisation von Dialysierffüssigkeit. Nieren-und Hochdruckkrankheiten 1997; 26: 468 (Abstract)